Biofrontera Inc. (NASDAQ: BFRI) is a biopharmaceutical company that dabbles in the dermatology domain. The company specializes in the revolutionary and innovative area of photodynamic
Biofrontera Inc. (BFRI) shares soared high on April 13, as its Germany lab got approval from FDA for testing skin disease therapy Ameluz®. But the
On April 7, 2022, Biofrontera Inc. (BFRI) had another day full of gains with an increase of 14.12% in regular trading followed by 14.60% after
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.